Publications

Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.

Locatelli SL

Clin Cancer Res. 2018 Oct 23;25(3):1098-1112. doi: 10.1158/1078-0432.CCR-18-1133

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.

Consonni FM

Front Immunol. 2019 May 3;10:949. doi: 10.3389/fimmu.2019.00949

Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells.

Travelli C

Cancer Res. 2019 Feb 18;79(8):1938-1951. doi: 10.1158/0008-5472.CAN-18-1544

Membrane Cholesterol Regulates Macrophage Plasticity in Cancer.

Sica A, Bleve A, Garassino MC

Cell Metab. 29(6):1238-1240. doi: 10.1016/j.cmet.2019.05.011

Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.

Porta C

Cancer Res. 2020 Apr 7;80(13):2874-2888. doi: 10.1158/0008-5472.CAN-19-2843

Immunometabolic Status of COVID-19 Cancer Patients.

Sica A

Physiol Rev. 2020 Jul 28;100(4):1839-1850. doi: 10.1152/physrev.00018.2020

Implications of metabolism-driven myeloid dysfunctions in cancer therapy.

Strauss L

Cell Mol Immunol. 2020 Oct 19;18(4):829-841. doi: 10.1038/s41423-020-00556-w

Heme catabolism by tumor-associated macrophages controls metastasis formation.

Consonni FM

Nat Immunol. 2021 Apr 26;22(5):595-606. doi: 10.1038/s41590-021-00921-5

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases.

Bleve A

Clin Rev Allergy Immunol. 2022 Jan 15;64(2):123-144. doi: 10.1007/s12016-021-08909-7

MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.

Castaldi A

Circ Res. 2014 May 7;115(2):273-83. doi: 10.1161/CIRCRESAHA.115.303252